ArticleAnti-Epithelial Growth Factor Receptors for Prognosis in Management of Metastatic Colorectal Cancer
ArticleAnti-Epithelial Growth Factor Receptors for Prognosis in Management of Metastatic Colorectal Cancer
ArticleThe Effect of Primary Tumor Site on Survival in Metastatic Colorectal Cancer Patients and their Relation to KRAS and Biological Therapy
ArticleThe Effect of Primary Tumor Site on Survival in Metastatic Colorectal Cancer Patients and their Relation to KRAS and Biological Therapy
ArticleAngiogenesis Versus Antiangiogenesis in Colorectal Cancer Patients with and Without Liver Metastases
ArticleAngiogenesis Versus Antiangiogenesis in Colorectal Cancer Patients with and Without Liver Metastases
ArticleRole of Metastatic Colon Cancer Topography in Pathological and Molecular Variability: A Retrospective Study
ArticleRole of Metastatic Colon Cancer Topography in Pathological and Molecular Variability: A Retrospective Study
ArticleERCC1, as Prognostic and Predictive Marker in Metastatic Colorectal Cancer Patients Treated with Oxaliplatin based Chemotherapy
ArticleERCC1, as Prognostic and Predictive Marker in Metastatic Colorectal Cancer Patients Treated with Oxaliplatin based Chemotherapy
ArticleDoes the number of metastatic organ involvement affect the response to irinotecan-based chemotherapy in patients with metastatic colorectal
ArticleDoes the number of metastatic organ involvement affect the response to irinotecan-based chemotherapy in patients with metastatic colorectal